Mayflower Financial Advisors LLC Trims Stock Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Mayflower Financial Advisors LLC trimmed its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 40.0% in the 4th quarter, HoldingsChannel reports. The firm owned 496 shares of the medical equipment provider’s stock after selling 330 shares during the quarter. Mayflower Financial Advisors LLC’s holdings in Intuitive Surgical were worth $259,000 at the end of the most recent quarter.

A number of other large investors have also recently modified their holdings of ISRG. Berbice Capital Management LLC purchased a new position in shares of Intuitive Surgical in the 4th quarter valued at approximately $26,000. Godsey & Gibb Inc. raised its holdings in Intuitive Surgical by 140.0% in the third quarter. Godsey & Gibb Inc. now owns 60 shares of the medical equipment provider’s stock worth $29,000 after purchasing an additional 35 shares in the last quarter. MidAtlantic Capital Management Inc. bought a new stake in shares of Intuitive Surgical during the 3rd quarter valued at $33,000. Decker Retirement Planning Inc. purchased a new stake in shares of Intuitive Surgical in the 4th quarter worth about $36,000. Finally, Capital Performance Advisors LLP purchased a new position in Intuitive Surgical during the 3rd quarter valued at about $38,000. Institutional investors own 83.64% of the company’s stock.

Analyst Upgrades and Downgrades

ISRG has been the subject of several recent research reports. UBS Group lifted their target price on shares of Intuitive Surgical from $500.00 to $560.00 and gave the company a “neutral” rating in a report on Monday. Leerink Partners raised their price target on Intuitive Surgical from $490.00 to $548.00 in a report on Monday. Morgan Stanley raised shares of Intuitive Surgical from an “equal weight” rating to an “overweight” rating and increased their price objective for the company from $522.00 to $650.00 in a research report on Monday, December 2nd. Oppenheimer reaffirmed a “market perform” rating on shares of Intuitive Surgical in a report on Friday, October 18th. Finally, CICC Research assumed coverage on shares of Intuitive Surgical in a report on Monday. They set a “neutral” rating and a $550.00 price target on the stock. One analyst has rated the stock with a sell rating, five have given a hold rating and sixteen have given a buy rating to the company’s stock. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $613.10.

Insider Transactions at Intuitive Surgical

In other Intuitive Surgical news, insider Jamie Samath sold 22,903 shares of the business’s stock in a transaction dated Friday, November 8th. The stock was sold at an average price of $525.00, for a total transaction of $12,024,075.00. Following the completion of the sale, the insider now owns 8,757 shares of the company’s stock, valued at approximately $4,597,425. The trade was a 72.34 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, EVP Robert Desantis sold 376 shares of the firm’s stock in a transaction dated Friday, November 29th. The stock was sold at an average price of $539.00, for a total value of $202,664.00. Following the completion of the transaction, the executive vice president now directly owns 5,506 shares in the company, valued at $2,967,734. This trade represents a 6.39 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 28,843 shares of company stock worth $15,357,560 in the last 90 days. 0.90% of the stock is currently owned by insiders.

Intuitive Surgical Trading Down 0.2 %

ISRG opened at $572.71 on Thursday. Intuitive Surgical, Inc. has a 12-month low of $364.17 and a 12-month high of $616.00. The company has a market cap of $203.99 billion, a price-to-earnings ratio of 92.08, a PEG ratio of 5.19 and a beta of 1.39. The company’s 50 day moving average is $548.70 and its 200 day moving average is $507.04.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.